Added IMPACT: The first successful natural birth using certolizumab in obstetric APS
Gespeichert in:
| Veröffentlicht in: | Thrombosis research 2024-09, Vol.241, p.109088, Article 109088 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 109088 |
| container_title | Thrombosis research |
| container_volume | 241 |
| creator | Madenidou, Anastasia-Vasiliki Kither, Hannah Dyball, Sarah Bruce, Ian N. Tower, Clare |
| description | |
| doi_str_mv | 10.1016/j.thromres.2024.109088 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3076423322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384824002202</els_id><sourcerecordid>3076423322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c245t-d52926f89e11810145491c795d988ed881c17eee2a2c2f470da8ef697a61f1933</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotl5eoWTpZmqSyUwSV5bipVBRsK5DmpyxKXOpSUbQp3ek6tbVgcP3n5_zITShZEoJLS-307QJXRMgThlhfFgqIuUBGlMpVMa4YIdoTAhXWS65HKGTGLeEUEFVcYxGuVSCKJWP0WrmHDi8eHiazVdXeLUBXPkQE469tRBj1de4NakPpsZrH9IG99G3r9hCSF3tP_vGrLFvcbeOCVLwFs-ens_QUWXqCOc_8xS93N6s5vfZ8vFuMZ8tM8t4kTJXMMXKSiqgVA5f8YIraoUqnJISnJTUUgEAzDDLKi6IMxKqUglT0oqqPD9FF_u7u9C99RCTbny0UNemha6POiei5CzPGRvQco_a0MUYoNK74BsTPjQl-tuo3upfo_rbqN4bHYKTn45-3YD7i_0qHIDrPQDDp-8ego7WQ2vB-QA2adf5_zq-AAKNifo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3076423322</pqid></control><display><type>article</type><title>Added IMPACT: The first successful natural birth using certolizumab in obstetric APS</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Madenidou, Anastasia-Vasiliki ; Kither, Hannah ; Dyball, Sarah ; Bruce, Ian N. ; Tower, Clare</creator><creatorcontrib>Madenidou, Anastasia-Vasiliki ; Kither, Hannah ; Dyball, Sarah ; Bruce, Ian N. ; Tower, Clare</creatorcontrib><identifier>ISSN: 0049-3848</identifier><identifier>ISSN: 1879-2472</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2024.109088</identifier><identifier>PMID: 38970993</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adult ; Anti-phospholipid syndrome ; Anti-TNF ; Antiphospholipid Syndrome - drug therapy ; Certolizumab ; Certolizumab Pegol - therapeutic use ; Female ; Humans ; Obstetric APS ; Pregnancy ; Pregnancy Complications - drug therapy</subject><ispartof>Thrombosis research, 2024-09, Vol.241, p.109088, Article 109088</ispartof><rights>2024 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c245t-d52926f89e11810145491c795d988ed881c17eee2a2c2f470da8ef697a61f1933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.thromres.2024.109088$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38970993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madenidou, Anastasia-Vasiliki</creatorcontrib><creatorcontrib>Kither, Hannah</creatorcontrib><creatorcontrib>Dyball, Sarah</creatorcontrib><creatorcontrib>Bruce, Ian N.</creatorcontrib><creatorcontrib>Tower, Clare</creatorcontrib><title>Added IMPACT: The first successful natural birth using certolizumab in obstetric APS</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><subject>Adult</subject><subject>Anti-phospholipid syndrome</subject><subject>Anti-TNF</subject><subject>Antiphospholipid Syndrome - drug therapy</subject><subject>Certolizumab</subject><subject>Certolizumab Pegol - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Obstetric APS</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><issn>0049-3848</issn><issn>1879-2472</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKAzEUhoMotl5eoWTpZmqSyUwSV5bipVBRsK5DmpyxKXOpSUbQp3ek6tbVgcP3n5_zITShZEoJLS-307QJXRMgThlhfFgqIuUBGlMpVMa4YIdoTAhXWS65HKGTGLeEUEFVcYxGuVSCKJWP0WrmHDi8eHiazVdXeLUBXPkQE469tRBj1de4NakPpsZrH9IG99G3r9hCSF3tP_vGrLFvcbeOCVLwFs-ens_QUWXqCOc_8xS93N6s5vfZ8vFuMZ8tM8t4kTJXMMXKSiqgVA5f8YIraoUqnJISnJTUUgEAzDDLKi6IMxKqUglT0oqqPD9FF_u7u9C99RCTbny0UNemha6POiei5CzPGRvQco_a0MUYoNK74BsTPjQl-tuo3upfo_rbqN4bHYKTn45-3YD7i_0qHIDrPQDDp-8ego7WQ2vB-QA2adf5_zq-AAKNifo</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Madenidou, Anastasia-Vasiliki</creator><creator>Kither, Hannah</creator><creator>Dyball, Sarah</creator><creator>Bruce, Ian N.</creator><creator>Tower, Clare</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202409</creationdate><title>Added IMPACT: The first successful natural birth using certolizumab in obstetric APS</title><author>Madenidou, Anastasia-Vasiliki ; Kither, Hannah ; Dyball, Sarah ; Bruce, Ian N. ; Tower, Clare</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c245t-d52926f89e11810145491c795d988ed881c17eee2a2c2f470da8ef697a61f1933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Anti-phospholipid syndrome</topic><topic>Anti-TNF</topic><topic>Antiphospholipid Syndrome - drug therapy</topic><topic>Certolizumab</topic><topic>Certolizumab Pegol - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Obstetric APS</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madenidou, Anastasia-Vasiliki</creatorcontrib><creatorcontrib>Kither, Hannah</creatorcontrib><creatorcontrib>Dyball, Sarah</creatorcontrib><creatorcontrib>Bruce, Ian N.</creatorcontrib><creatorcontrib>Tower, Clare</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madenidou, Anastasia-Vasiliki</au><au>Kither, Hannah</au><au>Dyball, Sarah</au><au>Bruce, Ian N.</au><au>Tower, Clare</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Added IMPACT: The first successful natural birth using certolizumab in obstetric APS</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2024-09</date><risdate>2024</risdate><volume>241</volume><spage>109088</spage><pages>109088-</pages><artnum>109088</artnum><issn>0049-3848</issn><issn>1879-2472</issn><eissn>1879-2472</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>38970993</pmid><doi>10.1016/j.thromres.2024.109088</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0049-3848 |
| ispartof | Thrombosis research, 2024-09, Vol.241, p.109088, Article 109088 |
| issn | 0049-3848 1879-2472 1879-2472 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3076423322 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adult Anti-phospholipid syndrome Anti-TNF Antiphospholipid Syndrome - drug therapy Certolizumab Certolizumab Pegol - therapeutic use Female Humans Obstetric APS Pregnancy Pregnancy Complications - drug therapy |
| title | Added IMPACT: The first successful natural birth using certolizumab in obstetric APS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A39%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Added%20IMPACT:%20The%20first%20successful%20natural%20birth%20using%20certolizumab%20in%20obstetric%20APS&rft.jtitle=Thrombosis%20research&rft.au=Madenidou,%20Anastasia-Vasiliki&rft.date=2024-09&rft.volume=241&rft.spage=109088&rft.pages=109088-&rft.artnum=109088&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2024.109088&rft_dat=%3Cproquest_cross%3E3076423322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3076423322&rft_id=info:pmid/38970993&rft_els_id=S0049384824002202&rfr_iscdi=true |